In Gl261 murine glioma, which is also sensitive to anti-CSF1R treatment, CSF1R-inhibition leads to TAM depletion with a more pronounced effect on the microglial fraction compared to macrophages [200]. The gene discussed is CSF1R; the disease is central nervous system cancer.